Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

Part of paid clinical trials in Kalamazoo, Michigan.

Sponsor
Western Michigan University School of Medicine
Study ID
NCT06395428
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Back Pain
  • Chronic Pain

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Haloperidol — DRUG
    Intramuscular injection of drug
  • Ketorolac Tromethamine — DRUG
    Intramuscular injection of drug

Study Details

Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of back pain. A total of 150 patients age 18-65 presenting to the emergency department with chief complaint of backpain will be enrolled from April 2024 - April 2025. Patients will be randomized and symptom levels will be recorded at 30, 60, 90, minutes. Follow-up will be performed by telephone at 24 hours.

Key Dates

Start date
Jul 9, 2024
Status verified
Jul 2024
Primary completion
Apr 15, 2025
Completion
Apr 15, 2027

Study Design

Enrollment
75 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Haloperidol
    Haloperidol 5 mg IM haloperidol
  • Active Comparator: Ketoralac
    Ketoralac 30 mg IM

Primary Outcome Measure

Visual Analog Scale (VAS) [ Time Frame: 30, 60, and 90 minutes after drug administration ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Bronson Methodist HospitalKalamazooMichigan49007
Jessica McCoy, MD
[email protected]
269-337-6600
Katharine Mitchell, PhD
[email protected]
269-341-8364

Find similar trials in Kalamazoo, MI

By research site
Bronson Methodist Hospital· Kalamazoo, MI

Related Studies